Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Edwards Lifesciences
(NY:
EW
)
69.96
-0.16 (-0.23%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Edwards Lifesciences
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Recap: Edwards Lifesciences Q1 Earnings
April 26, 2022
Edwards Lifesciences (NYSE:EW) reported its Q1 earnings results on Tuesday, April 26, 2022 at 04:15 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Medtech Giant Edwards Lifesciences Tumbles Despite First-Quarter Beat
April 26, 2022
The medtech giant narrowly beat first-quarter sales and earnings views.
Via
Investor's Business Daily
Earnings Scheduled For April 26, 2022
April 26, 2022
Companies Reporting Before The Bell • First American Financial (NYSE:FAF) is estimated to report quarterly loss at $0.09 per share on revenue of $46.41 million.
Via
Benzinga
Market Briefing For Monday, April 25
April 25, 2022
It's clearly on the edge of the generals completing their retreat to join troops already in the trenches. Nevertheless the same variables prevail; it's hard to project any sustainable rallies.
Via
Talk Markets
Establishment Labs Stock Clears Technical Benchmark, Hitting 90-Plus RS Rating
April 20, 2022
Establishment Labs stock cleared a key performance benchmark, with its Relative Strength Rating jumping to 92, up from 87 the day before.
Via
Investor's Business Daily
Inspire Medical Systems Stock Scores Relative Strength Rating Upgrade
April 20, 2022
Inspire Medical System stock reached an key technical benchmark, seeing its Relative Strength (RS) Rating jumping to 91.
Via
Investor's Business Daily
Expert Ratings for Edwards Lifesciences
April 13, 2022
Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter:
Via
Benzinga
Where Edwards Lifesciences Stands With Analysts
January 27, 2022
Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter:
Via
Benzinga
Edwards Lifesciences Dips On Narrow Quarterly Miss, Light Outlook
January 26, 2022
Edwards issued light 2022 guidance after a fourth-quarter disappointment.
Via
Investor's Business Daily
Five Of The Best Chinese Stocks To Keep An Eye On
April 16, 2022
This year has been a stellar one for the Chinese stock market. After a year that saw the Shanghai Stock
Via
Best Stocks
Pfizer Stock, Raytheon Lead 5 Stocks Near Buy Points
April 16, 2022
Pfizer, Raytheon lead stocks shielded from geopolitics and rate hikes.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2022
April 13, 2022
Upgrades
Via
Benzinga
Raytheon, Shell Lead Five Stocks Setting Up, Breaking Out From Strong Sectors
April 09, 2022
Raytheon and Shell are just below buy points. They have good company.
Via
Investor's Business Daily
7 Medical Device Stocks to Buy as Covid-19 Fears Fade
April 05, 2022
With concerns about Covid-19 fading into the rearview mirror, the normalization of healthcare could benefit these medical device stocks.
Via
InvestorPlace
3 Top S&P 500 Stock Market Gainers Today: Medicals Lead As This Sector Reverses Hard
April 01, 2022
Medical and gold stocks led the S&P 500. Transport stocks were big losers.
Via
Investor's Business Daily
FDA Approves Edwards Lifesciences' Resilia Valve For Mitral Replacement Surgery
March 31, 2022
The FDA has approved Edwards Lifesciences Corp's (NYSE: EW) Mitris Resilia valve, a tissue valve replacement specifically designed for the heart's mitral...
Via
Benzinga
What 9 Analyst Ratings Have To Say About Edwards Lifesciences
March 16, 2022
Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish...
Via
Benzinga
Analyst Ratings For Edwards Lifesciences
March 16, 2022
Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2022
March 16, 2022
Upgrades Bernstein upgraded the previous rating for Stryker Corp (NYSE:SYK) from Market Perform to Outperform. For the fourth quarter, Stryker had an EPS of $2.71, compared to...
Via
Benzinga
This Foreboding Sign Looms Over Edwards Lifesciences's Chart
March 14, 2022
If history is any guide, there may be trouble ahead for shares of Edwards Lifesciences (NYSE:EW). A so-called "death cross" has formed on its chart and, not surprisingly, this...
Via
Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022
February 02, 2022
Upgrades Oppenheimer upgraded the previous rating for NovoCure Ltd (NASDAQ:NVCR) from Perform to Outperform. NovoCure earned $0.13 in the third quarter, compared to $0.09...
Via
Benzinga
Stock Market Whipsaws Lower On Hawkish Fed, Tesla; Apple, Microsoft Earnings Strong: Weekly Review
January 28, 2022
Microsoft and Apple earnings were strong, but the correction is getting worse.
Via
Investor's Business Daily
Edwards Lifesciences Q4 Earnings Fall Short Of Expectations, Reaffirms FY22 Outlook
January 27, 2022
Heart device company Edwards Lifesciences Corp (NYSE: EW) posted Q4 adjusted EPS of $0.51, compared to $0.50 posted a year ago and below the consensus of $0.55....
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 26, 2022
Gainers Reneo Pharmaceuticals (NASDAQ:RPHM
Via
Benzinga
Edwards Lifesciences: Q4 Earnings Insights
January 26, 2022
Edwards Lifesciences (NYSE:EW) reported its Q4 earnings results on Wednesday, January 26, 2022 at 04:15 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data
January 26, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
5 Big Cap Earnings All Stars to Watch This Week
January 25, 2022
Some of these companies have perfect 5-year earnings surprise track records, even beating through the early months of the pandemic. It’s impressive.
Via
Talk Markets
Earnings Scheduled For January 26, 2022
January 26, 2022
Companies Reporting Before The Bell • Blue Foundry (NASDAQ:BLFY) is projected to report earnings for its fourth quarter. • First BanCorp (NYSE:FBP) is likely to...
Via
Benzinga
Preview: Edwards Lifesciences's Earnings
January 25, 2022
Edwards Lifesciences (NYSE:EW) is set to give its latest quarterly earnings report on Wednesday, 2022-01-26. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.